Combining health data with whole genome sequence data in cancer patients can help doctors provide more tailored care

Researchers evaluated the impact of integrating whole-genome sequencing data with clinical outcomes across 13,880 tumors from 33 cancer types, assessing precision care potentials within the UK NHS through the 100,000 Genomes Cancer Programme.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Sequencin Hiseq ,Cancer Programme ,National Genomic Test Directory ,Cambridge South Research Ethics Committee ,Research Environment ,National Cancer Registration ,Analysis Service ,Genomic Medicine Service ,Genomes Cancer Programme ,Public Health England ,Office For National Statistics ,National Genomic Research Library ,International Organization For Standardization ,United Kingdom National Healthcare System ,Nature Medicine ,National Healthcare System ,Image Credit ,United Kingdom Government ,International Organization ,Medicine Service ,National Genomic Test ,Sample Handling Guidance ,Illumina Truseq Polymerase Chain Reaction ,High Throughput Sequencin ,Illumina North Star ,Illumina Dragen ,Catalogue Of Somatic Mutations In Cancer ,Clinical Variant Database ,Genomic Tumor Advisory Boards ,Homologous Recombination Deficiency Detection ,England Cambridge South Research Ethics ,Cancer Genome Atlas ,Hospital Episode Statistics ,Molecular Tumor Boards ,Breast Cancer Type ,Cyclin Dependentkinase Inhibitor ,Cancer ,Enome ,Bioinformatics ,Arcinoma ,Carcinomas ,Na ,Gene ,Genes ,Enomic ,Genomics ,Germline ,Healthcare ,Illumina ,Medicine ,Ncology ,Pharmacogenomics ,Protein ,Research ,Software ,Humor ,